Citalopram NDC 68999-540

NDC codes

FDA NDC Directory

Product NDC (as listed)68999-540Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68999-0540Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68999-540-24	68999054024	2 TRAY in 1 BOX (68999-540-24) / 10 CUP in 1 TRAY / 10 mL in 1 CUP (68999-540-10)Marketed from Jan 13, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Citalopram
Generic name (nonproprietary): citalopram
Active ingredients: Citalopram hydrobromide — 10 mg/5mL
Dosage form: Solution
Route: Oral
Labeler: Chartwell Governmental & Specialty RX, LLC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077629
Marketing start: Jun 14, 2006
Listing expires: Dec 31, 2027
Other FDA classes: Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 68999-540_484c3f19-d5f7-3e00-e063-6394a90a1938SPL ID 484c3f19-d5f7-3e00-e063-6394a90a1938SPL set ID 3114274f-d81f-4b1f-8f17-35db9eee2ffeRxCUI 309313UNII I1E9D14F36
Pharmacologic class: Serotonin Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468999054024 followed by a unit qualifier and the quantity

Package 68999-0540-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 13, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Citalopram Oral Solution is indicated for the treatment of depression. The efficacy of Citalopram Oral Solution in the treatment of depression was established in 4 to 6 week, controlled trials of outpatients whose diagnosis corresponded most closely to the DSM-III and DSM-III-R category of major depressive disorder ( see CLINICAL PHARMACOLOGY ). A major depressive episode (DSM-IV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077629

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077629
Product	Strength	Form · route	Labeler	Product NDC
Citalopram	Citalopram hydrobromide 10 mg/5mL	SolutionOral	Chartwell RX, LLC	62135-540